Complete Guide to Online Ketamine Clinics

Online ketamine clinics provide at-home, sublingual ketamine treatment for depression, anxiety, and other conditions under the remote supervision of licensed clinicians. This complete guide to online ketamine clinics walks through how the telehealth model works, from the initial video evaluation to home dosing and ongoing monitoring, and explains what to check before choosing a provider. The model has grown quickly since 2020 as telehealth prescribing rules expanded and interest in ketamine's antidepressant effects increased among patients who had not responded to standard treatments. At-home ketamine also removes some of the access barriers tied to traditional infusion clinics, such as travel time and the cost of in-office IV sessions. The tradeoff is that dosing at home shifts more of the safety responsibility onto the patient and their support system, which is why provider vetting and medical screening matter as much as the medication itself.

Telehealth ketamine therapy is an at-home treatment model in which a licensed clinician evaluates a patient by video, then prescribes a form of ketamine the patient can take without an in-office visit. Ketamine is classified as a Schedule III controlled substance under the U.S. Controlled Substances Act, meaning it has an accepted medical use but also a recognized potential for misuse, which is why federal telehealth prescribing rules govern how it can be dispensed. Most online clinics dispense sublingual tablets or troches, small lozenge-like doses that dissolve under the tongue so the medication absorbs through the mouth rather than passing through the digestive system.

Patients complete a clinical evaluation by video, and if approved, a pharmacy ships the medication directly to their home. This differs from in-clinic ketamine infusion, where a provider administers the drug intravenously in a monitored office setting. The at-home model expanded quickly because telehealth flexibilities introduced during the COVID-19 public health emergency made remote prescribing of certain controlled substances possible, and later rules have kept parts of that flexibility in place. For the current legal picture on prescribing ketamine through telehealth, see our overview of telehealth prescribing legality.

Selecting a telehealth ketamine provider comes down to four factors: credentials, treatment approach, cost transparency, and state availability.

Credentials and licensing. Verify that the provider employs board-certified psychiatrists, psychiatric nurse practitioners, or other appropriately licensed clinicians, and confirm the prescribing clinician is licensed in your state of residence. Telehealth prescribing rules for controlled substances vary by state, and prescribing across state lines adds another layer of regulation; see our guide to interstate prescribing rules for ketamine.

Treatment approach. Providers use different models. Some focus on higher-dose, periodic sessions paired with integration therapy, while others use low-dose daily protocols. The right fit depends on your diagnosis, prior treatment history, and personal preference, so ask the provider to explain why they recommend one approach over another for your case.

Cost and transparency. Pricing varies significantly across providers. Look for a clear breakdown of what is included: consultation fees, medication costs, follow-up appointments, and any add-ons like coaching or integration therapy. Some providers charge per session while others use a subscription model; our comparison of subscription-based pricing and monthly subscription versus per-session costs can help you estimate what to budget. If cost is a concern, also check whether Medicare covers any part of treatment.

State availability. Not all providers serve all states, since telehealth prescribing rules for controlled substances differ by jurisdiction. Confirm a provider operates in your state before starting intake; our list of states with the most telehealth ketamine access and our state-by-state regulatory overview can help you check ahead of time. You can also browse our directory of online ketamine providers to compare options side by side.

Telehealth ketamine therapy is not the right fit for every diagnosis. Most online clinics focus on treatment-resistant depression, though some also treat anxiety disorders, PTSD, or other conditions when a clinician determines ketamine is appropriate. If you have bipolar disorder, screening needs to account for the risk of triggering a manic episode, since ketamine's stimulant-like effects can complicate mood stabilization; see our overview of ketamine telehealth considerations for bipolar disorder. Ketamine is also being studied for obsessive-compulsive disorder, but protocols and evidence differ from depression treatment; our guide to telehealth ketamine for OCD explains how providers approach that use case.

At-home treatment generally is not a fit for patients who need close, in-person monitoring because of unstable medical conditions, active suicidality requiring a higher level of care, or a home environment that cannot support a private, safe session. In those situations, an in-clinic infusion program with on-site staff is usually the safer starting point.

At-home ketamine therapy carries safety considerations that differ from in-clinic administration, where a clinician monitors the patient directly during dosing.

Medical screening. Comprehensive medical screening is a non-negotiable safety requirement. Patients with uncontrolled hypertension, certain cardiovascular conditions, active psychosis, or untreated substance use disorders may not be appropriate candidates for at-home ketamine therapy, and a responsible provider should say so during intake rather than after prescribing.

Treatment environment. Patients need a safe, private, and comfortable space for sessions. Most providers recommend having a sober support person present, particularly for the first few treatments, since ketamine affects coordination, perception, and judgment while it is active.

Medication management. Sublingual ketamine is a Schedule III controlled substance, so proper storage, handling, and disposal of unused medication are the patient's responsibility. Follow your provider's instructions on storage and disposal carefully, and never share prescribed medication with anyone else.

The at-home ketamine market has also drawn regulatory attention, which is a reminder to prioritize providers built around licensed clinicians, individualized screening, and documented follow-up rather than a seller that treats ketamine as a wellness product. For more on that scrutiny, see our coverage of federal reporting on online ketamine sellers.

Clinical evidence supports ketamine's efficacy for treatment-resistant depression (TRD), a diagnosis given when a patient has not responded to at least two adequate trials of standard antidepressants. Studies report response rates of roughly 60 to 70 percent in patients with TRD who had not improved on traditional antidepressants. According to a review published in the American Journal of Psychiatry, ketamine produces measurable antidepressant effects within hours to days of a single dose, a much faster onset than conventional antidepressants, which typically take several weeks to show benefit. Research in JAMA Psychiatry has reported similar rapid-onset findings.

The evidence base specific to at-home sublingual dosing is smaller than the evidence base for in-clinic IV ketamine and FDA-approved esketamine (Spravato), but it continues to grow. Several published studies report safety and efficacy for sublingual ketamine comparable to in-clinic protocols when proper monitoring is in place. The FDA has issued drug safety communications covering esketamine specifically, and prescribers of any ketamine formulation are expected to follow federal telehealth and controlled substance rules, including SAMHSA telehealth guidance and DEA controlled substance prescribing rules.

If you have already tried standard antidepressants without success, our guide to next steps for treatment-resistant depression and our overview of optimizing remission with ketamine telehealth go into more detail on how clinicians sequence these options.